1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Defence Therapeutics Inc.
  6. Financials
    DTC   CA24463V1013

DEFENCE THERAPEUTICS INC.

(DTC)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
Valuation
Fiscal Period: June 2021
Capitalization1 245
Enterprise Value (EV)1 240
P/E ratio -65,6x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
Price to Book 45,3x
Nbr of stocks (in thousands) 34 801
Reference price (CAD) 7,05
Announcement Date 10/27/2021
1 CAD in Million
Income Statement Evolution (Annual data)
Fiscal Period: June 2019 2020 2021
Net sales ---
EBITDA ---
Operating profit (EBIT)1 -0,04-0,67-2,83
Operating Margin ---
Pre-Tax Profit (EBT)1 -0,00-0,67-2,86
Net income1 -0,00-0,67-2,86
Net margin ---
EPS --0,71-0,11
Dividend per Share ---
Announcement Date 02/02/202110/27/202110/27/2021
1 CAD in Million
Balance Sheet Analysis
Fiscal Period: June 2019 2020 2021
Net Debt1 ---
Net Cash position1 0,001,875,45
Leverage (Debt / EBITDA) ---
Free Cash Flow --0,24-1,20
ROE (Net Profit / Equities) --72,2%-77,8%
Shareholders' equity1 -0,933,68
ROA (Net Profit / Asset) --43,8%-47,0%
Assets1 -1,546,09
Book Value Per Share -0,100,16
Cash Flow per Share -0,100,15
Capex ---
Capex / Sales ---
Announcement Date 02/02/202110/27/202110/27/2021
1 CAD in Million
Key data
Capitalization (CAD) 109 556 622
Capitalization (USD) 84 718 772
Free-Float 93,9%
Free-Float capitalization (CAD) 102 906 811
Free-Float capitalization (USD) 79 576 556
Avg. Exchange 20 sessions () 18 368
Avg. Exchange 20 sessions (USD) 0,00
Average Daily Capital Traded 0,02%
EPS & Dividend